<VariationArchive VariationID="6626" VariationName="NM_006412.4(AGPAT2):c.377dup (p.Pro128fs)" VariationType="Duplication" Accession="VCV000006626" Version="4" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2014-11-29" MostRecentSubmission="2022-12-31">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21665" VariationID="6626">
      <GeneList>
        <Gene Symbol="AGPAT2" FullName="1-acylglycerol-3-phosphate O-acyltransferase 2" GeneID="10555" HGNC_ID="HGNC:325" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136673143" stop="136687457" display_start="136673143" display_stop="136687457" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139567594" stop="139581910" display_start="139567594" display_stop="139581910" Strand="-" />
          </Location>
          <OMIM>603100</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_006412.4(AGPAT2):c.377dup (p.Pro128fs)</Name>
      <CanonicalSPDI>NC_000009.12:136677075:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="136677075" stop="136677076" display_start="136677075" display_stop="136677076" variantLength="1" positionVCF="136677075" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="139571527" stop="139571528" display_start="139571527" display_stop="139571528" variantLength="1" positionVCF="139571527" referenceAlleleVCF="C" alternateAlleleVCF="CA" />
      </Location>
      <ProteinChange>P128fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.139571528dup" Assembly="GRCh37">
            <Expression>NC_000009.11:g.139571528dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.136677076dup" Assembly="GRCh38">
            <Expression>NC_000009.12:g.136677076dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008090.1" sequenceAccession="NG_008090" sequenceVersion="1" change="g.15384dup">
            <Expression>NG_008090.1:g.15384dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001012727.2" sequenceAccession="NM_001012727" sequenceVersion="2" change="c.377dup">
            <Expression>NM_001012727.2:c.377dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001012745.1" sequenceAccession="NP_001012745" sequenceVersion="1" change="p.Pro128fs">
            <Expression>NP_001012745.1:p.Pro128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006412.4" sequenceAccession="NM_006412" sequenceVersion="4" change="c.377dup" MANESelect="true">
            <Expression>NM_006412.4:c.377dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006403.2" sequenceAccession="NP_006403" sequenceVersion="2" change="p.Pro128fs">
            <Expression>NP_006403.2:p.Pro128fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277945" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603100.0003" DB="OMIM" />
        <XRef Type="rs" ID="387906355" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00005" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00008" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006412.4(AGPAT2):c.377dup (p.Pro128fs) AND Congenital generalized lipodystrophy type 1" Accession="RCV000007005" Version="13">
        <ClassifiedConditionList TraitSetID="1835">
          <ClassifiedCondition DB="MedGen" ID="C1720862">Congenital generalized lipodystrophy type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-05-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2014-11-29" MostRecentSubmission="2022-12-31">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11967537</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1835" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5410" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital generalized lipodystrophy type 1</ElementValue>
                <XRef ID="Congenital+Generalized+Lipodystrophy+Type+1/1829" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012071" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BRUNZELL SYNDROME, AGPAT2-RELATED</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BSCL1</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CGL1</ElementValue>
                <XRef Type="MIM" ID="608594" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="84" />
                <XRef ID="84" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality.</Attribute>
                <XRef ID="NBK1212" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301391</ID>
                <ID Source="BookShelf">NBK1212</ID>
              </Citation>
              <XRef ID="528" DB="Orphanet" />
              <XRef ID="C1720862" DB="MedGen" />
              <XRef ID="MONDO:0012071" DB="MONDO" />
              <XRef Type="MIM" ID="608594" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27201" SubmissionDate="2014-11-26" DateLastUpdated="2014-11-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603100.0003_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1" title="AGPAT2, 1-BP INS, 377T_LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1" />
        <ClinVarAccession Accession="SCV000027201" DateUpdated="2014-11-29" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a U.S. African American family, Agarwal et al. (2002) found that 2 individuals, aged 29 and 31 years, with congenital generalized lipodystrophy-1 (CGL1; 608594) were compound heterozygotes for the AGPAT2 IVS4-2A-G splice site mutation (603100.0002) and a 1-bp deletion, 377insT, which caused a frameshift mutation beginning with leu126 and ending with premature termination at codon 146.</Attribute>
              <Citation>
                <ID Source="PubMed">11967537</ID>
              </Citation>
              <XRef DB="OMIM" ID="608594" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGPAT2" />
          </GeneList>
          <Name>AGPAT2, 1-BP INS, 377T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 377T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603100.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5456358" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_006412.4:c.377dup|OMIM:608594" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002808733" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006412.4:c.377dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608594" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4932429" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-28" DateCreated="2022-05-28">
        <ClinVarSubmissionID localKey="NC_000009.12:g.136677075_136677076insA|OMIM:608594" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002517537" DateUpdated="2022-05-28" DateCreated="2022-05-28" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AGPAT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.12:g.136677075_136677076insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608594" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4932429" TraitType="Disease" MappingType="XRef" MappingValue="608594" MappingRef="OMIM">
        <MedGen CUI="C1720862" Name="Congenital generalized lipodystrophy type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5456358" TraitType="Disease" MappingType="XRef" MappingValue="608594" MappingRef="OMIM">
        <MedGen CUI="C1720862" Name="Congenital generalized lipodystrophy type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27201" TraitType="Disease" MappingType="Name" MappingValue="LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1" MappingRef="Preferred">
        <MedGen CUI="C1720862" Name="Congenital generalized lipodystrophy type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

